Benzothiazole Derivatives as CK-1 Inhibitors for the Treatment of Amyotrophic Lateral Sclerosis

05 Abr Benzothiazole Derivatives as CK-1 Inhibitors for the Treatment of Amyotrophic Lateral Sclerosis

[one_fourth]
[/one_fourth][three_fourth_last][box]CSIC has synthesized a family of benzothiazoles which acts as casein kinase 1 (CK-1) inhibitors. Therefore, these compounds are useful for the treatment of diseases related to circadian rhythm and neurodegenerative, inflammatory, autoimmune, neurological and psychiatric diseases where CK-1 is relevant. Furthermore, these compounds induce cell regeneration.[/box]

Download
[/three_fourth_last]